Biotech Not Cratering, Just Deflating To see where the biotech sector is headed tomorrow, it might be helpful for investors […]

Cuba seeks new drug markets Inside modern towers that are a pride of Fidel Castro, scientists peer through huge microscopes

Time to Let the Air Out If you think biotech stocks are headed for a breakout anytime soon, allow us

FDA rules need tweaking The biotech industry is suffering a mini-crisis of confidence that mirrors the larger shocks that have

deCODED? A new map of the human genome should help both doctors and biologists

Will R&D Make Merck Hot Again? The drug giant gets out of the prescription business and bets it all on

Will R&D Make Merck Hot Again? The drug giant gets out of the prescription business and bets it all on

Cracking the cancer code Whether a tumor invades the lung or breast is beside the point. Its genetic activity will

Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the

Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the